MacroGenics Inc - Company Profile
Powered by
All the data and insights you need on MacroGenics Inc in one report.
- Save hours of research time and resources with
our up-to-date MacroGenics Inc Strategy Report
- Understand MacroGenics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
MacroGenics Catalyst Calendar
Proactively evaluate MacroGenics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of MacroGenics Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
31 Dec 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
01 Dec 2019 | Phase I Trial Initiation | MacroGenics Inc | MGNX | flotetuzumab; retifanlimab | Oncology | Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia); Refractory Acute Myeloid Leukemia; Relapsed Acute Myeloid Leukemia | Company Press Release |
01 Dec 2019 | Phase III Trial Initiation | Baxter International Inc; MacroGenics Inc; Zai Lab Ltd | BAX; MGNX; ZLAB | margetuximab | Oncology | Breast Cancer; Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer); Metastatic Breast Cancer | Clinical Trial Registry |
01 Dec 2019 | Phase II Trial Results | American Diabetes Association; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation; MacroGenics Inc; National Center for Research Resources; National Institute of Health; The Hospital for Sick Children; The National Institute of Allergy and Infectious Diseases; The National Institute of Diabetes and Digestive and Kidney Diseases; TrialNet; U.S. National Institutes of Health | MGNX | teplizumab | Metabolic Disorders | Pre-Diabetes/Impaired Glucose Tolerance; Type 1 Diabetes (Juvenile Diabetes) | Company Presentation |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer